Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
$0.91−0.06 (-5.84%)
Close on Nov 17, 2026Market cap $47.67MP/E –Yield –
Rafael price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Rafael's price to sales ratio was 64.1× on Nov 11, 2026, against 37.9× a year earlier. Over the last 5 years it ranged from 16.0× to 176.4×, with a median of 69.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 64.1× | +23.1 |
| 2025 | Dec 31, 2025 | 41.0× | −16.0 |
| 2024 | Dec 31, 2024 | 56.9× | −97.8 |
| 2023 | Dec 29, 2023 | 154.7× | +20.3 |
| 2022 | Dec 30, 2022 | 134.5× | +106.1 |
| 2021 | Dec 31, 2021 | 28.4× | −49.2 |
| 2020 | Dec 31, 2020 | 77.6× | +26.8 |
| 2019 | Dec 31, 2019 | 50.8× | +28.3 |
| 2018 | Dec 31, 2018 | 22.5× | – |
See a number that looks wrong?